The New Zealand AIDS Foundation applauds PHARMAC’s decision to become one of the first countries in the world to publicly fund the HIV-prevention drug Pre-Exposure Prophylaxis (PrEP) – meaning those at high risk of HIV have another way to protect themselves.
Scooped by
Matt Skallerud
onto Health, HIV & Addiction Topics in the LGBTQ+ Community |